We are monitoring the impact of COVID-19 on APAC Gamma Knife Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7967
Share on
Share on

Asia Pacific Gamma Knife Market Research Report - Segmented By Disease Indication & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 7967
Pages: 145

APAC Gamma Knife Market Size & Growth (2021 to 2026):

As per the research report, the size of the Asia Pacific Gamma Knife Market is valued at USD 59.35 million in 2021 and estimated to be growing at a CAGR of 9.63%, to reach USD 93.99 million by 2026. Gamma knife is a radiation therapy which is highly focused for spinal or brain cancer which involves a high-dose radiation therapy in a single treatment.

Radiation therapy is a procedure which entails accurate delivery of radiation of high doses to tumors and other appropriate anatomical targets. Gamma Knife is an important form of radiation therapy. It is chiefly used to treat arteriovenous malformations, brain tumors, acoustic neuroma, trigeminal neuralgia and pituitary tumors. In Gamma Knife beam procedure, specialized equipment focuses close to a couple of hundred tiny beams of radiation on a tumor or other targeted cells. These beams deliver powerful doses of radiation to specific tumor cells with refined accuracy. This effectively implies that surrounding healthy tissues are exposed to minimum or no radiation whatsoever.

The driving factors of Asia Pacific Gamma Knife market are growing prevalence of cancer, obesity and rising aging population. Also, growing number of initiatives which are undertaken by several government associations and the state-of-the-art features of Gamma Knife systems are also propelling the growth of the market. However, the market is constrained by factors such as prolonged approval time for Gamma Knife systems and stringent regulatory framework, high price of implementation and shortage of skilled manpower among others.

This research report segmented and sub-segmented into the following categories:

  • By Disease Indication: Brain Metastasis, Cancer, Trigeminal Neuralgia, AVM And Others
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Brain metastasis holds the largest market share for gamma knife, accounting to more than sixty percent of share. The others segment is expected to grow at the fastest rate during the forecast period.

Asia Pacific region has the second largest market for gamma knife in the world by share. This region is expected to overtake the North America region in terms of share in the forecast period. Factors such as growing prevalence of cancer and rising aging population are expected to drive the market growth in the forecast period.

The Top companies leading in the APAC Gamma Knife Market profiled in the report are Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini Asia Pacific, Inc., Hokai, Nordion Inc., ET Medical group and American Shared Hospital Services among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease Indication                   

                                5.1.1 Brain Metastasis   

                                5.1.2 Cancer      

                                5.1.3 Trigeminal Neuralgia           

                                5.1.4 AVM (Arteriovenous Malformation)           

                                5.1.5 Others      

                                5.1.6  Y-o-Y Growth Analysis, By Disease Indication          

                                5.1.7  Market Attractiveness Analysis, By Disease Indication        

                                5.1.8  Market Share Analysis, By Disease Indication         

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Disease Indication

                                6.1.4  Market Attractiveness Analysis     

                                       By Disease Indication

                                6.1.5  Market Share Analysis      

                                       By Disease Indication

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Varian Medical Systems                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Elekta AB                     

                8.3 Cyber Medical Corporation Ltd.                         

                8.4 Huiheng Medical Inc.                              

                8.5 Masep Infini Global, Inc.                       

                8.6 Hokai                             

                8.7 Nordion Inc.                               

                8.8 ET Medical group                     

                8.9 American Shared Hospital Services                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Disease Indication, by  By Region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. Asia Pacific Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )
  2. Asia Pacific Brain Metastasis Market By Region, From 2021 to 2026 ( USD Million )
  3. Asia Pacific Cancer Market By Region, From 2021 to 2026 ( USD Million )
  4. Asia Pacific Trigeminal Neuralgia Market By Region, From 2021 to 2026 ( USD Million )
  5. Asia Pacific AVM  Market By Region, From 2021 to 2026 ( USD Million )
  6. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  7. Japan Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )
  8. China Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )
  9. India Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )
  10. Australia Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )
  11. South Korea Gamma Knife  Market By Disease Indication , From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample